AzarGen Biotechnologies
OperatingAzarGen is a biotech company focused on developing human therapeutic proteins using advanced genetic engineering & synthetic biology
- Biotechnology
- Stellenbosch, South Africa
- Series B
- Founded 2009
- azargen.com ↗
- Total raised
- $3.1M
- disclosed
- Last round
- $3.1M
- Series B
- Rounds
- 1
- since 2009
- Employees
- 1-10
About AzarGen Biotechnologies
AzarGen is a biotechnology company focused on developing human therapeutic proteins using advanced genetic engineering and synthetic biology techniques in plants. The company’s lead therapeutic candidates are: a biosimilar version of an anti-cancer monoclonal antibody and a recombinant human surfactant protein targeted for various respiratory disease conditions. AzarGen has developed proprietary synthetic DNA promoters for various expression platform applications in plant-made pharmaceuticals, synthetic biology and GM-crop improvement. The AzarGen management team is supported by an experienced advisory board for strategic guidance and intellectual property management. Based in Stellenbosch, South Africa, AzarGen is supported by South Africa’s Industrial Development Corporation (IDC).
AzarGen Biotechnologies funding1 round
AzarGen Biotechnologies has raised $3.1M across 1 disclosed round. The latest is a $3.1M Series B announced 07 Jan 2016.
| Announced | Round | Lead · investors | Amount |
|---|---|---|---|
| 07 Jan 2016 | AzarGen Biotechnologies Series B | Not disclosed | $3.1M |
AzarGen Biotechnologies founders & team
AzarGen Biotechnologies competitorssame sector · similar funding
- Genius BiotherapeuticsTokai, South Africa
- Altera BiosciencesTshwane, South Africa
More Biotechnology startups in South Africa
- BixBio
Bixbio is a biotechnology company working to unlock the potential of diverse genetic data in Africa to transform the field of precision medicine. · South Africa
- Fluorobiotech
Fluorobiotech expands access to high‑quality enzymes powering global biotech innovation. · South Africa
- AgriProtein
Agriprotein specializes in nutrient recycling to create sustainable sources of protein for the mono-gastric animal feed industry. · South Africa
- Ethomed
Ethomed develops treatments for neglected diseases. · South Africa
- LifeQ
LifeQ is a SA biotech startup which provides users with access to health information derived from wearable devices. · South Africa
- Inseco
Inseco is redefining protein creation & facilitating the transition towards a circular economy · South Africa
Frequently asked about AzarGen Biotechnologies
- Where is AzarGen Biotechnologies based and when was it founded?
- AzarGen Biotechnologies is headquartered in Stellenbosch, South Africa and was founded in 2009.
- Who is the CEO of AzarGen Biotechnologies?
- Mauritz Venter is AzarGen Biotechnologies' CEO.
- How much funding has AzarGen Biotechnologies raised?
- AzarGen Biotechnologies has raised $3.1M across 1 disclosed round. Its latest, a $3.1M Series B, was announced on Jan 07, 2016.
- What sector is AzarGen Biotechnologies in?
- AzarGen Biotechnologies operates in Biotechnology and Genetics.
